Article

Will the Republicans Vote to Repeal the ACA?

Author(s):

The 2014 midterm elections changed the balance of power in Washington. The Republicans now have majorities in both the US Senate and the US House of Representatives. Will that mean the end of the Affordable Care Act?

(Click the play button on the audio player above to listen to this segment of the ACA panel discussion)

This HCPLive audio panel discussion features:

  • Joel Zinberg MD, JD, Associate Clinical Professor of Surgery at Mount Sinai Hospital in New York City
  • David Sandman PhD, Senior Vice President of the New York State Health Foundation
  • Patrick Cronin, New Jersey organizing director for “Get Covered America” a nonprofit with a federal contract to help people sign up for coverage
  • Tom Wilson (moderator), a partner at Kaufman Zita Group and former chairman of the NJ Republican State Committee

The panelists look at how well the ACA is working and discuss whether it is politically vulnerable.

The 2014 midterm elections changed the balance of power in Washington. The Republicans now have majorities in both the US Senate and the US House of Representatives. Will that mean the end of the ACA?

On a scale of 1 to 10, the panelists were asked to rate the prospects of repealing the ACA. Cronin said 1 to 2; Sandman said zero.

“The ACA is here to stay as long as President Obama remains the president” Sandman says.

Zinberg sees an alternative to repealing the ACA: he predicts the GOP will make “major parts of the law disappear in the next 2 years.” Those could include removing the employer mandate to provide insurance.

An unpopular tax on medical devices will likely disappear, the panelists agree. “The medical device tax is dead,” says Zinberg.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
© 2024 MJH Life Sciences

All rights reserved.